Wednesday, 4 November 2026Live feed

Guangzhou Cloudy 30°CAbout

M

Meridian Globe全球版

A global news aggregation portal

Live briefing

Ethics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei Asia Cyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia Singapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei Asia The great yen rebalancing— 日经 Nikkei Asia Nintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei Asia North Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei Asia Japan's IHI wins key role in Westinghouse's new Poland nuclear plant— 日经 Nikkei Asia US experts warm to Japanese nuclear subs as check on China in Asian waters— 日经 Nikkei Asia Ethics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei Asia Cyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia Singapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei Asia The great yen rebalancing— 日经 Nikkei Asia Nintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei Asia North Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei Asia Japan's IHI wins key role in Westinghouse's new Poland nuclear plant— 日经 Nikkei Asia US experts warm to Japanese nuclear subs as check on China in Asian waters— 日经 Nikkei Asia

Dual mTORC1/2 and Scd1 inhibition uncovers a therapeutic vulnerability in pancreatic cancer

Source Nature 生命科学Published 31 Oct 2026, 08:003d ago

Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Desk: Science
Region: Global
Language: English
Item ID: science-67301586

Comments 0 comments

No comments yet. Be the first.

Dual mTORC1/2 and Scd1 inhibition uncovers a therapeutic vulnerability in pancreatic cancer · Meridian Globe